Szántó Antónia
Szántó Antónia
Debreceni Egyetem, Klinikai Központ
E-mail megerősítve itt: med.unideb.hu
Cím
Hivatkozott rá
Hivatkozott rá
Év
Follicular helper T cells may play an important role in the severity of primary Sjögren's syndrome
K Szabo, G Papp, S Barath, E Gyimesi, A Szanto, M Zeher
Clinical immunology 147 (2), 95-104, 2013
1102013
A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus
K Szabó, G Papp, A Szántó, T Tarr, M Zeher
Clinical & Experimental Immunology 183 (1), 76-89, 2016
762016
Similarities and differences between pediatric and adult patients with systemic lupus erythematosus
T Tarr, B Dérfalvi, N Győri, A Szántó, Z Siminszky, A Malik, AJ Szabo, ...
Lupus 24 (8), 796-803, 2015
722015
Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjögren's syndrome
M Zeher, IF Horvath, A Szanto, P Szodoray
Thyroid 19 (1), 39-45, 2009
492009
Clinical, serologic, and genetic profiles of patients with associated Sjögren’s syndrome and systemic lupus erythematosus
A Szanto, P Szodoray, E Kiss, A Kapitany, G Szegedi, M Zeher
Human immunology 67 (11), 924-930, 2006
462006
Genome‐scale assessment of molecular pathology in systemic autoimmune diseases using microarray technology: a potential breakthrough diagnostic and individualized therapy …
M Centola, MB Frank, AI Bolstad, P Alex, A Szanto, M Zeher, ...
Scandinavian Journal of Immunology 64 (3), 236-242, 2006
412006
Clinical course, prognosis, and cause of death in primary Sjögren’s syndrome
IF Horvath, A Szanto, G Papp, M Zeher
Journal of immunology research 2014, 2014
362014
Functional and morphological evaluation of hand microcirculation with nailfold capillaroscopy and laser Doppler imaging in Raynaud's and Sjögren's syndrome and poly/dermatomyositis
N Szabo, Z Csiki, A Szanto, K Danko, P Szodoray, M Zeher
Scandinavian journal of rheumatology 37 (1), 23-29, 2008
282008
Decreased human paraoxonase-1 activity in patients with Sjögren's syndrome
A Szántó, M Harangi, I Seres, G Paragh, M Zeher
International immunology 22 (7), 605-609, 2010
152010
Autoantibodies to alfa-fodrin in patients with Hashimoto thyroiditis and Sjögren’s syndrome: possible markers for a common secretory disorder
A Szanto, I Csipo, I Horvath, E Biro, P Szodoray, M Zeher
Rheumatology international 28 (11), 1169, 2008
152008
Lack of association of vitamin D receptor gene polymorphisms/haplotypes in Sjögren’s syndrome
E Zilahi, JQ Chen, G Papp, A Szántó, M Zeher
Clinical rheumatology 34 (2), 247-253, 2015
142015
Intrapulmonary rheumatoid nodules in a patient with long-standing rheumatoid arthritis treated with leflunomide
IF Horvath, A Szanto, Z Csiki, P Szodoray, M Zeher
Pathology & Oncology Research 14 (1), 101-104, 2008
122008
Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjögren's
A Szántó, I Csípo, M Zeher
The Journal of Rheumatology 32 (1), 197, 2005
72005
Description of patients with IgG4-related disease from a Hungarian centre
A Szanto, G Nagy, CS Molnár, Z Griger, T Tarr, M Zeher
Scandinavian journal of rheumatology 43 (4), 334-337, 2014
62014
Treatment of hypertension in patients with rheumatic diseases.
D Pall, A Szanto, C Farsang
Blood pressure 22 (6), 399, 2013
52013
Autoantibodies to novel membrane and cytosolic antigens of the lachrymal gland in primary Sjögren’s syndrome
P Szodoray, K Koczok, A Szanto, IF Horvath, B Nakken, I Molnar, M Zeher
Clinical rheumatology 27 (2), 195-199, 2008
52008
Association of systemic lupus erythematosus and Sjögren's syndrome
A Szántó, E Kiss, A Sas, G Szegedi, M Zeher
Orvosi hetilap 146 (50), 2533-2538, 2005
52005
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study
BA Fisher, A Szanto, WF Ng, M Bombardieri, MG Posch, AS Papas, ...
The Lancet Rheumatology, 2020
42020
FRI0174 SUBCUTANEOUS DOSING OF THE NOVEL ANTI-CD40 ANTIBODY ISCALIMAB ACHIEVES TARGET DRUG EXPOSURE AND CLINICAL EFFICACY IN PRIMARY SJÖGREN’S SYNDROME; RESULTS OF A PHASE IIA …
B Fisher, A Szántó, WF Ng, M Bombardieri, M Posch, A Papas, A Farag, ...
Annals of the Rheumatic Diseases 78 (Suppl 2), 760-761, 2019
42019
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients
S Retamozo, N Acar-Denizli, A Rasmussen, IF Horvath, C Baldini, R Priori, ...
Clinical and Experimental Rheumatology 37 (3 (S118)), 97-106, 2019
32019
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20